Shown verbatim: the complete text as captured from the official page posted by the Washington Legislature, fetched 2026-08-29. This is the chaptered version. The official bill page.
CERTIFICATION OF ENROLLMENT SUBSTITUTE SENATE BILL 6183 Chapter 48, Laws of 2026 69TH LEGISLATURE 2026 REGULAR SESSION HEALTH PLANS—HIV ANTIVIRAL DRUG COVERAGE EFFECTIVE DATE: June 11, 2026 Passed by the Senate February 10, 2026 Yeas 48 Nays 0 DENNY HECK President of the Senate Passed by the House March 3, 2026 Yeas 93 Nays 1 LAURIE JINKINS Speaker of the House of Representatives CERTIFICATE I, Sarah Bannister, Secretary of the Senate of the State of Washington, do hereby certify that the attached is SUBSTITUTE SENATE BILL 6183 as passed by the Senate and the House of Representatives on the dates hereon set forth. SARAH BANNISTER Secretary Secretary Approved March 14, 2026 11:29 AM FILED March 16, 2026 BOB FERGUSON Governor of the State of Washington Secretary of State State of Washington SUBSTITUTE SENATE BILL 6183 Passed Legislature - 2026 Regular Session State of Washington 69th Legislature 2026 Regular Session By Senate Health & Long-Term Care (originally sponsored by Senators Liias, Harris, Bateman, Cleveland, C. Wilson, Dhingra, Hasegawa, Nobles, Pedersen, Saldaña, Stanford, Trudeau, and Valdez) READ FIRST TIME 01/29/26. AN ACT Relating to coverage for HIV antiviral drugs; reenacting and amending RCW 41.05.017; and adding a new section to chapter 48.43 RCW. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON: NEW SECTION. Sec. 1. A new section is added to chapter 48.43 RCW to read as follows: (1) For health plans issued or renewed on or after January 1, 2027, except as provided in subsection (2) of this section, a health carrier shall provide coverage for all federal food and drug administration approved HIV antiviral drugs without prior authorization, step therapy, or any other utilization management protocols. (2) If the United States food and drug administration has approved one or more therapeutic equivalents of a drug, device, or product for the prevention or treatment of HIV, this section does not require a health plan to cover all of the therapeutically equivalent versions without prior authorization, step therapy, or any other utilization management protocols, if at least one therapeutically equivalent version is covered without prior authorization, step therapy, or any other utilization management protocols. Sec. 2. RCW 41.05.017 and 2025 c 389 s 3 and 2025 c 171 s 2 are each reenacted and amended to read as follows: Each health plan that provides medical insurance offered under this chapter, including plans created by insuring entities, plans not subject to the provisions of Title 48 RCW, and plans created under RCW 41.05.140, are subject to the provisions of RCW 48.43.500, 70.02.045, 48.43.505 through 48.43.535, 48.43.537, 48.43.545, 48.43.550, 70.02.110, 70.02.900, 48.43.190, 48.43.083, 48.43.0128, 48.43.780, 48.43.435, 48.43.815, 48.200.020 through 48.200.280, 48.200.300 through 48.200.320, 48.43.440, 48.43.845, 48.43.732, section 1 of this act, and chapter 48.49 RCW. Passed by the Senate February 10, 2026. Passed by the House March 3, 2026. Approved by the Governor March 14, 2026. Filed in Office of Secretary of State March 16, 2026.
Every fact on this page links to its source, starting with the official bill record.